The Cancer Letter highlights UC kidney cancer research
The Cancer Letter highlighted the University of Cincinnati Cancer Center’s Maria Czyzyk-Krzeska's new NIH-funded research that will investigate how copper contributes to the advancement and recurrence of clear cell renal cell carcinoma (ccRCC).
Research has found that increased accumulation of copper is associated with worse outcomes for patients with ccRCC, the most common type of kidney cancer.
“That indicated to us that copper has a potential driving effect in tumor progression of clear cell renal cell carcinoma,” said Czyzyk-Krzeska, a University of Cincinnati Cancer Center researcher and professor in the Department of Cancer Biology in UC’s College of Medicine.
The study will seek to identify the mechanisms that allow ccRCC cells to take up more copper, copper’s metabolic effects on the tumor cells and whether any of the copper-specific features of the tumor cells have vulnerabilities that can open up new treatments for ccRCC.
“There are essentially two or three major lines of treatment for kidney cancer, but ultimately there’s always a group of tumors that are not responsive or recur” said Czyzyk-Krzeska. “We hope what we find is going to provide opportunities for new treatments.”
Read The Cancer Letter article.
Featured photo at top of periodic table highlighting copper. Photo/HT Ganzo/iStock.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.